09.04.18The facility in Ashdod is one of five Teva intends to sell or close in its home country
25.10.17The stem-cell therapy company diluted Teva’s shares through a new offering in August
09.10.17Co-founder Aaron Shaked’s heirs sold their entire stake for nearly $300 million